Novel Strategies for Anterior Segment Ocular Drug Delivery

Tekijä Cholkar, Kishore, Patel, Sulabh P., Vadlapudi, Aswani Dutt, Mitra, Ashim K.
Julkaistu 2013

SYSTEMATIC EVALUATION OF DRUG-DISEASE RELATIONSHIPS TO IDENTIFY LEADS FOR NOVEL DRUG USES

Tekijä Chiang, Annie P., Butte, Atul J.
Julkaistu 2009

Novel drug targets based on metallobiology of Alzheimer’s disease

Tekijä Bandyopadhyay, Sanghamitra, Huang, Xudong, Lahiri, Debomoy K, Rogers, Jack T
Julkaisussa Expert Opin Ther Targets (2010)

Novel botanical drug DA-9803 prevents deficits in Alzheimer’s mouse models

Tekijä Pagnier, Guillaume J., Kastanenka, Ksenia V., Sohn, Miwon, Choi, Sangzin, Choi, Song-hyen, Soh, HyeYeon, Bacskai, Brian J.
Julkaisussa Alzheimers Res Ther (2018)

Epigenetic targets for novel therapies of lung diseases

Tekijä Comer, Brian S., Ba, Mariam, Singer, Cherie A., Gerthoffer, William T.
Julkaisussa Pharmacol Ther (2014)

Lifitegrast: a novel drug for patients with dry eye disease

Tekijä Haber, Stacy L., Benson, Vera, Buckway, Casey J., Gonzales, Jennifer M., Romanet, David, Scholes, Brittany
Julkaisussa Ther Adv Ophthalmol (2019)

Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer

Tekijä May FEB
Julkaistu 2014-05-01

Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M(4) Muscarinic Receptor as a Novel Therapeutic Target

Tekijä Gogliotti, Rocco G., Fisher, Nicole M., Stansley, Branden J., Jones, Carrie K., Lindsley, Craig W., Conn, P. Jeffrey, Niswender, Colleen M.
Julkaisussa J Pharmacol Exp Ther (2018)

A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction

Tekijä Hay, Meredith, Polt, Robin, Heien, Michael L., Vanderah, Todd W., Largent-Milnes, Tally M., Rodgers, Kathleen, Falk, Torsten, Bartlett, Mitchell J., Doyle, Kristian P., Konhilas, John P.
Julkaisussa J Pharmacol Exp Ther (2019)

Structure and dynamics of molecular networks: A novel paradigm of drug discovery: A comprehensive review

Tekijä Csermely, Peter, Korcsmáros, Tamás, Kiss, Huba J.M., London, Gábor, Nussinov, Ruth
Julkaistu 2013

THER-28. A CK1α ACTIVATOR PENETRATES THE BRAIN, AND SHOWS EFFICACY AGAINST DRUG-RESISTANT METASTATIC MEDULLOBLASTOMA

Tekijä Rodriguez, Jezabel, Li, Bin, Long, Jun, Shen, Chen, Yang, Fan, Orthon, Darren, Collins, Sara, Kasahara, Noriyuki, Ayad, Nagi, McCrea, Heather, Roussel, Martine, Weiss, William, Capobianco, Anthony, Robbins, David
Julkaisussa Neuro Oncol (2019)

Artificial intelligence-based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer’s disease

Tekijä Tsuji, Shingo, Hase, Takeshi, Yachie-Kinoshita, Ayako, Nishino, Taiko, Ghosh, Samik, Kikuchi, Masataka, Shimokawa, Kazuro, Aburatani, Hiroyuki, Kitano, Hiroaki, Tanaka, Hiroshi
Julkaisussa Alzheimers Res Ther (2021)

Novel antibody–drug conjugates for triple negative breast cancer

Tekijä Nagayama, Aiko, Vidula, Neelima, Ellisen, Leif, Bardia, Aditya
Julkaisussa Ther Adv Med Oncol (2020)

Commentary: A Novel Disease-Drug Database Demonstrating Applicability for Pharmacogenomic-Based Prescribing

Tekijä Whirl-Carrillo, M., Sangkuhl, K., Gong, L., Klein, T.E.
Julkaisussa Clin Pharmacol Ther (2016)

A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism

Tekijä Daugherty, Daniel, Goldberg, Joshua, Fischer, Wolfgang, Dargusch, Richard, Maher, Pamela, Schubert, David
Julkaisussa Alzheimers Res Ther (2017)

Self-Nanoemulsifying Drug Delivery System of Genkwanin: A Novel Approach for Anti-Colitis-Associated Colorectal Cancer

Tekijä Yin, Hua-Feng, Yin, Chun-Ming, Ouyang, Ting, Sun, Shu-Ding, Chen, Wei-Guo, Yang, Xiao-Lin, He, Xin, Zhang, Chun-Feng
Julkaisussa Drug Des Devel Ther (2021)

VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs

Tekijä Schub, David, Assmann, Gunter, Sester, Urban, Sester, Martina, Schmidt, Tina
Julkaisussa Arthritis Res Ther (2018)

Apremilast: A Novel PDE4 Inhibitor in the Treatment of Autoimmune and Inflammatory Diseases

Tekijä Schett, Georg, Sloan, Victor S., Stevens, Randall M., Schafer, Peter
Julkaistu 2010

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease

Tekijä Öhrfelt, Annika, Brinkmalm, Ann, Dumurgier, Julien, Brinkmalm, Gunnar, Hansson, Oskar, Zetterberg, Henrik, Bouaziz-Amar, Elodie, Hugon, Jacques, Paquet, Claire, Blennow, Kaj
Julkaisussa Alzheimers Res Ther (2016)

Exploring prospects of novel drugs for tuberculosis

Tekijä Janssen, Saskia, Jayachandran, Rajesh, Khathi, Lulama, Zinsstag, Jakob, Grobusch, Martin P, Pieters, Jean
Julkaistu 2012